Journal of Clinical Medicine,
Год журнала:
2023,
Номер
12(14), С. 4649 - 4649
Опубликована: Июль 12, 2023
Since
the
beginning
of
COVID-19
pandemic
in
March
2020,
an
intimate
relationship
between
this
disease
and
cardiovascular
diseases
has
been
seen.
However,
few
studies
assess
development
heart
failure
during
infection.
This
study
aims
to
determine
predisposing
factors
for
(HF)
hospital
admission
patients.A
retrospective
multicenter
patients
with
HF
admitted
150
Spanish
hospitals
(SEMI-COVID-19
Registry).
A
bivariate
analysis
was
performed
relate
different
variables
evaluated
developing
admission.
multivariate
including
most
relevant
clinical
obtained
analyses
predict
outcome
performed.A
total
16.474
hospitalized
were
included
(57.5%
men,
mean
age
67
years),
958
them
(5.8%)
developed
hospitalization.
The
risk
were:
(odds
ratio
[OR]):
1.042;
confidence
interval
95%
(CI
95%):
1.035-1.050;
p
<
0.001),
atrial
fibrillation
(OR:
2.022;
CI
95%:
1.697-2.410;
BMI
>
30
kg/m2
1.460
1.230-1.733;
0001),
peripheral
vascular
1.564;
1.217-2.201;
0.001).
Patients
who
had
a
higher
rate
mortality
(54.1%
vs.
19.1%,
intubation
2,36;
ICU
admissions
2.38;
0001).Patients
presented
older
factors.
age,
fibrillation,
obesity,
disease.
In
addition,
more
frequently
required
be
intubated
or
ICU.
International Journal of Molecular Sciences,
Год журнала:
2024,
Номер
25(5), С. 2973 - 2973
Опубликована: Март 4, 2024
The
endothelium
is
a
monocellular
layer
covering
the
inner
surface
of
blood
vessels.
It
maintains
vascular
homeostasis
regulating
tone
and
permeability
exerts
anti-inflammatory,
antioxidant,
anti-proliferative,
anti-thrombotic
functions.
When
exposed
to
detrimental
stimuli
including
hyperglycemia,
hyperlipidemia,
neurohormonal
imbalance,
different
biological
pathways
are
activated
leading
oxidative
stress,
endothelial
dysfunction,
increased
secretion
adipokines,
cytokines,
endothelin-1,
fibroblast
growth
factor,
reduced
nitric
oxide
production,
eventually
loss
integrity.
Endothelial
dysfunction
has
emerged
as
hallmark
dysmetabolic
impairment
contributes
effects
on
cardiac
metabolism
diastolic
development
cardiovascular
diseases
heart
failure.
Different
biomarkers
have
been
proposed
predict
in
order
identify
microvascular
macrovascular
damage
atherosclerosis,
particularly
metabolic
disorders.
also
plays
an
important
role
severe
COVID-19
complications
patients
after
SARS-CoV-2
infection.
In
this
review,
we
will
discuss
mechanisms
involved
dysregulation
context
cardiometabolic
well
available
promising
clinical
practice.
Circulation Research,
Год журнала:
2024,
Номер
134(12), С. 1767 - 1790
Опубликована: Июнь 6, 2024
Autoimmunity
significantly
contributes
to
the
pathogenesis
of
myocarditis,
underscored
by
its
increased
frequency
in
autoimmune
diseases
such
as
systemic
lupus
erythematosus
and
polymyositis.
Even
cases
myocarditis
caused
viral
infections,
dysregulated
immune
responses
contribute
pathogenesis.
However,
whether
triggered
existing
conditions
or
precise
antigens
immunologic
pathways
driving
remain
incompletely
understood.
The
emergence
associated
with
checkpoint
inhibitor
therapy,
commonly
used
for
treating
cancer,
has
afforded
an
opportunity
understand
mechanisms
autoreactive
T
cells
specific
cardiac
myosin
playing
a
pivotal
role.
Despite
their
self-antigen
recognition,
myosin-specific
can
be
present
healthy
individuals
due
bypassing
thymic
selection
stage.
In
recent
studies,
novel
modalities
suppressing
activity
pathogenic
including
have
proven
effective
myocarditis.
This
review
offers
overview
current
understanding
heart
antigens,
autoantibodies,
underlying
various
forms
along
latest
updates
on
clinical
management
prospects
future
research.
Open Heart,
Год журнала:
2025,
Номер
12(1), С. e002914 - e002914
Опубликована: Янв. 1, 2025
Background
Studies
have
shown
an
increased
risk
of
cardiac
disease
following
COVID-19,
but
how
it
compares
to
pneumonia
other
etiologies
is
unclear.
Aims
To
determine
the
incidence
and
HRs
in
patients
hospitalised
with
COVID-19
compared
viral
or
bacterial
pneumonias.
Methods
Using
nationwide
registry
data,
we
estimated
events
after
hospitalisation
(n=2082)
February
November
2020
vs
(n=9018)
(n=29
339)
2018–2019.
We
defined
outcomes
using
ICD-10
codes
for
incident
myocarditis,
acute
myocardial
infarction,
atrial
fibrillation/flutter,
heart
failure,
ischaemic
disease,
total
(any
condition).
used
Cox
regression
logistic
analysis.
Results
Patients
had
a
mean
(SD)
age
60
(18)
years,
69
(19)
years
72
(17)
pneumonia.
Those
were
more
often
male
fewer
comorbidities
prior
hospitalisations.
lower
hazard
new-onset
(HR
0.79
[95%CI
0.66
0.93])
0.57
0.78]),
adjusted
age,
sex,
comorbidity,
hospital
admission
year
respiratory
support.
similar
when
including
recurrent
events.
Conclusion
during
first
9
months
pneumonias
adjusting
multiple
possible
confounders.
However,
there
may
still
be
residual
confounding
from
unknown
factors.
European Journal of Clinical Investigation,
Год журнала:
2024,
Номер
54(8)
Опубликована: Апрель 8, 2024
The
adult
mammalian
heart
contains
a
large
population
of
pericytes
that
play
important
roles
in
homeostasis
and
disease.
In
the
normal
heart,
regulate
microvascular
permeability
flow.
Myocardial
diseases
are
associated
with
marked
alterations
pericyte
phenotype
function.
This
review
manuscript
discusses
role
cardiac
Following
myocardial
infarction
(MI),
participate
all
phases
repair.
During
inflammatory
phase,
may
secrete
cytokines
chemokines
leukocyte
trafficking,
through
formation
intercellular
gaps
serve
as
exit
points
for
cells.
Moreover,
contraction
induces
constriction,
contributing
to
pathogenesis
'no-reflow'
ischemia
reperfusion.
proliferative
activated
by
growth
factors,
such
transforming
factor
(TGF)-β
contribute
fibrosis,
predominantly
secretion
fibrogenic
mediators.
A
fraction
acquires
fibroblast
identity
but
contributes
only
small
percentage
infarct
fibroblasts
myofibroblasts.
As
scar
matures,
form
coat
around
neovessels,
promoting
stabilization
vasculature.
Pericytes
also
be
involved
chronic
failure,
regulating
inflammation,
angiogenesis
perfusion.
targets
viral
infections
(such
SARS-CoV2)
implicated
complications
COVID19.
Considering
their
fibrosis
angiogenesis,
promising
therapeutic
Various
symptoms
have
been
reported
to
persist
beyond
acute
phase
of
severe
respiratory
syndrome
coronavirus
2
(SARS-CoV-2)
infection,
which
is
referred
as
long
disease
19
(long
COVID-19).
Over
65
million
individuals
suffer
from
COVID-19.
However,
the
causes
COVID-19
largely
unknown.
Since
are
observed
throughout
body,
vascular
endothelial
dysfunction
may
be
a
strong
candidate
induce
The
angioten-sin-converting
enzyme
(ACE2),
entry
receptor
SARS-CoV-2,
ubiquitously
expressed
in
cells.
We
previously
found
that
risk
factors
for
athero-sclerotic
cardiovascular
(ASCVD)
and
history
ASCVD
can
COVID-19,
suggesting
contribution
pre-existing
Here,
we
show
significant
association
with
development
biomarkers
patients
also
crucial
players
ASCVD.
consider
influence
on
chronic
kidney
(CKD)
Furthermore,
suggest
therapeutic
interventions
by
considering
treatment
tar-gets
Such
prevent
pandemic
CKD
post
era.
Cells,
Год журнала:
2023,
Номер
12(17), С. 2154 - 2154
Опубликована: Авг. 27, 2023
COVID-19
had
stormed
through
the
world
in
early
March
of
2019,
and
on
5
May
2023,
SARS-CoV-2
was
officially
declared
to
no
longer
be
a
global
health
emergency.
The
rise
new
variants
XBB.1.5
XBB.1.16,
product
recombinant
sub-strains,
has
fueled
need
for
continued
surveillance
pandemic
as
they
have
been
deemed
increasingly
infectious.
Regardless
severity
variant,
this
caused
an
increase
hospitalizations,
strain
resources,
concern
public
health.
In
addition,
there
is
growing
population
patients
experiencing
cardiovascular
complications
result
post-acute
sequelae
COVID-19.
This
review
aims
focus
what
known
about
its
past
(Alpha,
Delta,
Omicron)
how
knowledge
grown
today
with
emerging
variants,
emphasis
complexities.
We
possible
mechanisms
that
cause
observations
chronic
cardiac
conditions
seen
even
after
recovered
from
infection.
Further
understanding
these
will
help
close
gap
differences
between
effects
variants.
Biomolecules,
Год журнала:
2024,
Номер
14(8), С. 965 - 965
Опубликована: Авг. 8, 2024
Various
symptoms
have
been
reported
to
persist
beyond
the
acute
phase
of
severe
respiratory
syndrome
coronavirus
2
(SARS-CoV-2)
infection,
which
is
referred
as
long
disease
19
(long
COVID-19).
Over
65
million
individuals
suffer
from
COVID-19.
However,
causes
COVID-19
are
largely
unknown.
Since
observed
throughout
body,
vascular
endothelial
dysfunction
a
strong
candidate
explaining
induction
The
angiotensin-converting
enzyme
(ACE2),
entry
receptor
for
SARS-CoV-2,
ubiquitously
expressed
in
cells.
We
previously
found
that
risk
factors
atherosclerotic
cardiovascular
(ASCVD)
and
history
ASCVD
raise
COVID-19,
suggesting
contribution
pre-existing
Here,
we
show
significant
association
with
development
biomarkers
patients
also
crucial
players
ASCVD.
consider
influence
on
chronic
kidney
(CKD)
Future
assessments
outcomes
resulting
therapeutic
interventions
improve
function
may
imply
significance
British Journal of Pharmacology,
Год журнала:
2024,
Номер
unknown
Опубликована: Ноя. 21, 2024
Background
and
Purpose
Accumulating
evidence
suggests
circulating
microRNAs
(miRNAs)
are
important
regulators
of
biological
processes
involved
in
COVID‐19
complications.
We
sought
to
assess
whether
miRNAs
associated
with
clinical
phenotype
outcome.
Experimental
Approach
To
discover
signatures
disease
severity
mortality,
miRNA
quantification
was
performed
on
plasma
samples
collected
at
hospital
admission
from
a
cohort
106
patients
mild
or
severe
COVID‐19.
Variable
importance
projection
scoring
partial
least
squared
discriminant
analysis
Random
Forest
Classifier
were
employed
identify
key
severity.
ROC
detect
promising
able
discriminate
between
COVID
status.
Key
Results
Hsa‐miR‐1‐3p
the
most
differentiating
who
developed
severe,
rather
than
mild,
disease.
levels
rose
increasing
severity,
highest
prolonged
length
stay
worse
survival.
Longitudinal
profiling
demonstrated
that
hsa‐miR‐1‐3p
expression
significantly
increased
during
acute
infection
compared
those
observed
6
months
after
onset.
Specific
blockade
miR‐1‐3p
SARS‐CoV‐2–infected
endothelial
cells
decreased
up‐regulation
genes
endothelial‐to‐mesenchymal
transition,
inflammation
thrombosis.
Furthermore,
inhibition
reversed
impaired
angiogenic
capacity
induced
by
Conclusion
Implications
Our
data
establish
novel
role
for
pathogenesis
provide
strong
rationale
its
usefulness
as
early
prognostic
biomarkers
status
Current Opinion in Physiology,
Год журнала:
2023,
Номер
35, С. 100704 - 100704
Опубликована: Июль 21, 2023
Myocarditis
is
frequently
caused
by
viral
infections,
but
animal
models
that
closely
resemble
human
disease
suggest
virus-triggered
autoimmune
the
most
likely
cause
of
myocarditis.
a
rare
condition
occurs
primarily
in
men
under
age
50.
The
incidence
myocarditis
rose
at
least
15x
during
COVID-19
pandemic
from
1-10
to
150-400
cases/100,000
individuals,
with
cases
occurring
vaccination
was
also
associated
young
50
years
an
as
high
individuals
reported
for
some
mRNA
vaccines.
Sex
differences
immune
response
are
virtually
identical
mechanisms
known
drive
sex
pre-COVID
based
on
clinical
studies
and
models.
many
similarities
between
vaccine-associated
non-COVID
common
disease.
Bioengineering & Translational Medicine,
Год журнала:
2023,
Номер
9(3)
Опубликована: Авг. 8, 2023
Abstract
Coronavirus
disease
2019
(COVID‐19)
has
been
a
major
global
health
concern
since
its
emergence
in
2019,
with
over
680
million
confirmed
cases
as
of
April
2023.
While
COVID‐19
strongly
associated
the
development
cardiovascular
complications,
specific
mechanisms
by
which
viral
infection
induces
myocardial
dysfunction
remain
largely
controversial
studies
have
shown
that
severe
acute
respiratory
syndrome
coronavirus‐2
can
lead
to
heart
failure
both
directly,
causing
damage
cells,
and
indirectly,
triggering
an
inflammatory
response
throughout
body.
In
this
review,
we
summarize
current
understanding
potential
drive
based
on
vitro
studies.
We
also
discuss
significance
three‐dimensional
heart‐on‐a‐chip
technology
context
future
pandemics.